Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-12-18
2007-12-18
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S326000, C435S338000, C435S346000, C435S810000, C530S387100, C530S388100, C530S389100
Reexamination Certificate
active
11445988
ABSTRACT:
The present invention provides novel polynucleotides encoding BGS-42 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel BGS-42 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
REFERENCES:
patent: 6734284 (2004-05-01), Johansen et al.
patent: WO00/55173 (2000-09-01), None
patent: WO00/58473 (2000-10-01), None
Attwood et al, Science 2000. 290:471-473.
Skolnick et al, Trends in Biotech. 2000. 18(1):34-39.
Lederman et al. Molecular Immunology. 1991. 28:1171-1181.
Li et al. PNAS 1980. 77:3211-3214.
Muller et al. Analytical Biochemistry, 259:54-61 (1998).
Altschul, et al., “Gapped Blast and PSI-BLAST: a new generation of protein database search programs”, Nucleic Acids Res., vol. 25 (17), pp. 3389-3402 (1997).
Bateman, et al., “The Pfam Protein Families Database”, Nucleic Acids Res., vol. 28(1), pp. 263-266 (2000).
Birney, et al., “Using GeneWise in theDrosophilaAnnotation Experiment”, Genome Res., vol. 10, pp. 547-548 (2000).
Bonaldo, et al., “Normalization and Subtraction: Two Approaches to Facilitate Gene Discovery”, Genome Res., vol. 6, pp. 791-806 (1996).
Carninci, et al., “[2] High-Efficiency Full-Length cDNA Cloning”, Methods Enzy., vol. 303, pp. 19-44 (1999).
Dunham, et al., “The DNA sequence of human chromosome 22”, Nature, vol. 402, pp. 489-495 (1999).
Elgar, et al., “Generation and Analysis of 25 Mb of Genomic DNA from the PufferfishFugu rubripesby Sequence Scanning”, Genome Res., vol. 9, pp. 960-971 (1999).
Ersfeld, et al., “Characterization of the Tubulin-Tyrosine Ligase”, J. Cell Biol., vol. 120(3), pp. 725-732 (1993).
Herman, et al., “Methylation-specific PCR: A novel PCR assay for methylation status of GpG islands”, PNAS, vol. 93, pp. 9821-9826 (1996).
Idriss, H.T., “Suppression of tubulin tyrosine ligase activity through reversible phosphorylation: a mechanism for inhibition of α-tubulin tyrosinylation”, Medical Hypotheses, vol. 56(2), pp. 129-133 (2001).
Mialhe, et al., “Tubulin Detyrosination Is a Frequent Occurrence in Breast Cancers of Poor Prognosis”, Cancer Res., vol. 61, pp. 5024-5027 (2001).
Needleman, et al., “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins”, J. Mol. Biol., vol. 48, pp. 443-453 (1970).
Raybin, et al., “Enzyme Which Specifically Adds Tyrosine to the α Chain of Tubulin”, Biochem., vol. 16(10), pp. 2189-2194 (1977).
Takai, et al., “Comprehensive analysis of CpG islands in human chromosomes 21 and 22”, PNAS, vol. 99(6), pp. 3740-3745 (2002).
Trichet, et al., Characterization of the human tubulin tyrosine ligase-like 1 gene (TTLL1) mapping to 22q13.1, Gene, vol. 257, pp. 109-117 (2000).
Wiemann, et al., “Toward a Catalog of Human Genes and Proteins: Sequencing and Analysis of 500 Novel Complete Protein Coding Human cDNAs”, Genome Res., vol. 11, pp. 422-435 (2001).
NCBI Entrez Accession No. A45443 (gi:423218), Ersfeld, et al., Jun. 3, 2002.
NCBI Entrez Accession No. AAF23353 (gi:6683745), Yu, et al., Jan. 9, 2000.
NCBI Entrez Accession No. AA061487 (gi:1555346), Marra, et al., Feb. 3, 1997.
NCBI Entrez Accession No. AA144756 (gi:1714179), Marra, et al., Feb. 11, 1997.
NCBI Entrez Accession No. AF078842 (gi:6683744), Yu, et al., Jan. 9, 2000.
NCBI Entrez Accession No. AI026623 (gi:3246111), NCI-CGAP, Aug. 27, 1998.
NCBI Entrez Accession No. AL022327 (gi:5304851), Cobley, V., May 18, 2005.
NCBI Entrez Accession No. AL026623 (gi:3263966), Elgar, et al., Feb. 25, 2004.
NCBI Entrez Accession No. AL096725 (gi:5419858), Wambutt, et al., Feb. 18, 2000.
NCBI Entrez Accession No. BB004438 (gi:8093886), Konno, et al., Jun. 22, 2000.
NCBI Entrez Accession No. BE102364 (gi:8494463), Bonaldo, et al., Jun. 13, 2000.
NCBI Entrez Accession No. BM808516 (gi:19125339), NIH-MGC, Mar. 5, 2002.
NCBI Entrez Accession No. BM808637 (gi:19125460), NIH-MGC., Mar. 5, 2002.
NCBI Entrez Accession No. BU937372 (gi:24126191), NIH-MGC, Oct. 18, 2002.
NCBI Entrez Accession No. CAB46375 (gi:5419859), Wambutt, et al., Feb. 18, 2000.
NCBI Entrez Accession No. CAI42686 (gi:57208207), Cobley, V., May 18, 2005.
NCBI Entrez Accession No. CK604006 (gi:41117345), NIH-MGC, Jan. 22, 2004.
NCBI Entrez Accession No. CK653583 (gi:41389106), NIH-MGC, Jan. 29, 2004.
NCBI Entrez Accession No. CR745100 (gi:51667573), Ebert, et al., Dec. 21, 2004.
NCBI Entrez Accession No. CX205198 (gi:56860370), Williams, C., Dec. 29, 2004.
NCBI Entrez Accession No. DN831611 (gi:62640254), Stevens, et al., Apr. 27, 2005.
NCBI Entrez Accession No. DN831612 (gi:62640255), Stevens, et al., Apr. 27, 2005.
NCBI Entrez Accession No. DN831950 (gi:62640634), Stevens, et al., Apr. 27, 2005.
NCBI Entrez Accession No. DN831951 (gi:62640635), Stevens, et al., Apr. 27, 2005.
NCBI Entrez Accession No. DR008133 (gi:66272229), Stevens, et al., May 18, 2005.
NCBI Entrez Accession No. DR008134 (gi:66272231), Stevens, et al., May 18, 2005.
NCBI Entrez Accession No. Q9Y4R7 (gi:20455371), Yu, et al., Sep. 13, 2005.
NCBI Entrez Accession No. T12515 (gi:597202), Liew, et al., Nov. 28, 1994.
NCBI Entrez Accession No. XP—104657 (gi:37564887), NCBI Annotation Process, Feb. 19, 2004.
NCBI Entrez Accession No. XP—104657 (gi:51476104), NCBI Annotation Process, Aug. 20, 2004.
NCBI Entrez Accession No. XP—515212 (gi:55661552), NCBI Annotation Process,, Nov. 9, 2004.
Baylin, et al., “Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer”, Human Molecular Genetics, vol. 10(7), pp. 687-692 (2001).
ENSEMBL:ENSP00000266182, Jan. 14, 2004.
NCBI Entrez Accession No. gi|NP—766406, Okazaki, Y. et al., Dec. 22, 2003.
Carninci, P. et al., “High-Efficiency Full-Length cDNA Cloning”, Methods in Enzymology, vol. 303, pp. 19-44 (1999).
Carninci, P. et al., “Normalization and Subtraction of Cap-Trapper-Selected cDNAs to Prepare Full-Length cDNA Libraries for Rapid Discovery of New Genes”, Genome Research, vol. 10, pp. 1617-1630 (2000).
Shibata, K. et al., “RIKEN Integrated Sequence Analysis (RISA) System—384-Format Sequencing Pipeline with 384 Multicapillary Sequencer”, Genome Research, vol. 10, pp. 1757-1771 (2000).
The FANTOM Consortium and the RIKEN Genome Exploration Research Group Phase I & II Team, “Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs”, Nature, vol. 420, pp. 563-573 (2002).
The RIKEN Genome Exploration Research Group Phase II Team and the FANTOM Consortium, “Functional annotation of a full-length mouse cDNA collection”, Nature, vol. 409, pp. 685-690 (2001).
Feder John N.
Lee Liana M.
Nelson Thomas C.
Wu Shujian
Bristol--Myers Squibb Company
D'Amico Stephen C.
Gambel Phillip
Wen Sharon
LandOfFree
Antibodies directed to the testis-specific tubulin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies directed to the testis-specific tubulin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies directed to the testis-specific tubulin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3883154